Sebag-Montefiore D - Search Results

1

Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.

Jones CM, Adams R, Downing A, Glynne-Jones R, Harrison M, Hawkins M, Sebag-Montefiore D, Gilbert DC, Muirhead R. Jones CM, et al. Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1202-1211. doi: 10.1016/j.ijrobp.2018.04.033. Epub 2018 Apr 19. Int J Radiat Oncol Biol Phys. 2018. PMID: 29859793 Free article.

2

Chemoradiation schedules--what radiotherapy?

Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. Eur J Cancer. 2002 Jan;38(2):258-69. doi: 10.1016/s0959-8049(01)00370-7. Eur J Cancer. 2002. PMID: 11803142 Review.

3

Rectal cancer: what can we learn from the Dutch TME Study? How will this study impact on current practice in the U.K?

Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. Clin Oncol (R Coll Radiol). 2002 Apr;14(2):170-3. doi: 10.1053/clon.2001.0025. Clin Oncol (R Coll Radiol). 2002. PMID: 12069126 No abstract available.

4

Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resection.

Patel K, Anthoney DA, Crellin AM, Sebag-Montefiore D, Messruther J, Seymour MT. Patel K, et al. Ann Oncol. 2004 Apr;15(4):568-73. doi: 10.1093/annonc/mdh134. Ann Oncol. 2004. PMID: 15033660 Free article. Clinical Trial.

5

Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy.

Charnley N, Choudhury A, Chesser P, Cooper RA, Sebag-Montefiore D. Charnley N, et al. Br J Cancer. 2005 Apr 11;92(7):1221-5. doi: 10.1038/sj.bjc.6602486. Br J Cancer. 2005. PMID: 15798772 Free PMC article. Clinical Trial.

6

A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study.

Sebag-Montefiore D, Glynne-Jones R, Falk S, Meadows HM, Maughan T. Sebag-Montefiore D, et al. Br J Cancer. 2005 Oct 31;93(9):993-8. doi: 10.1038/sj.bjc.6602818. Br J Cancer. 2005. PMID: 16249791 Free PMC article. Clinical Trial.

7

A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer.

Glynne-Jones R, Sebag-Montefiore D, Maughan TS, Falk SJ, McDonald AC. Glynne-Jones R, et al. Ann Oncol. 2006 Jan;17(1):50-6. doi: 10.1093/annonc/mdj031. Epub 2005 Nov 10. Ann Oncol. 2006. PMID: 16284060 Free article. Clinical Trial.

8

The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?

Glynne-Jones R, Dunst J, Sebag-Montefiore D. Glynne-Jones R, et al. Ann Oncol. 2006 Mar;17(3):361-71. doi: 10.1093/annonc/mdj052. Ann Oncol. 2006. PMID: 16500912 Free article. Review.

9

Role of neoadjuvant chemotherapy in rectal cancer: interpretation of the EXPERT study.

Glynne-Jones R, Sebag-Montefiore D. Glynne-Jones R, et al. J Clin Oncol. 2006 Oct 1;24(28):4664-5; author reply 4665-6. doi: 10.1200/JCO.2006.07.9491. J Clin Oncol. 2006. PMID: 17008708 No abstract available.

10

A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.

Glynne-Jones R, Falk S, Maughan TS, Meadows HM, Sebag-Montefiore D. Glynne-Jones R, et al. Br J Cancer. 2007 Feb 26;96(4):551-8. doi: 10.1038/sj.bjc.6603570. Epub 2007 Jan 30. Br J Cancer. 2007. PMID: 17262086 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters